Naftizin® [Naphazoline]

In otolaryngology: intranasal (in each nasal passage), adults are prescribed 1-3 cap 0.05-0.1% solution 3-4 times a day. In children, 0.05% aqueous solution (or 0.025% solution is used, diluting 0.05% solution with distilled water): from 1 to 6 years - 1-2 drops, from 6 to 15 years - 2 drops 1-3 times a day. For diagnostic purposes, after cleaning the nose, instill 3-4 drops in each nasal passage or insert a tampon dipped in 0.05% aqueous solution and leave for 1-2 minutes; With swelling of the vocal cords, inject 1-2 ml of solution in the form of a spray or in small doses with a laryngeal syringe; for bleeding, swabs moistened with a 0.05% solution. In ophthalmology: 1-2 cap 0.05% solution in the cavity of the conjunctiva, 1-3 times a day. As an additional drug for surface anesthesia - 2-4 cap per 1 ml of local anesthetic.

Adverse reactions

Nausea, tachycardia, headache, increased blood pressure, reactive hyperemia, swelling of the nasal mucosa. Irritation, when used for more than 1 week - swelling of the mucous membrane of the nasal cavity, atrophic rhinitis.

Contraindications

Hypersensitivity; arterial hypertension, marked atherosclerosis, thyrotoxicosis, children's age (up to 1 year), chronic rhinitis, serious eye diseases, diabetes mellitus; simultaneous administration of MAO inhibitors and a period of up to 14 days after the end of their use.

Drug interactions

It should not be used simultaneously with MAO inhibitors or within 10 days after the end of their use. Slows down the absorption of local anesthetic drugs (lengthens their action during surface anesthesia).

Pregnancy and Lactation

Special instructions

Overdosage